IP Library › Granted Patent US 12,285,457
Granted Patent B2
US 12,285,457 · App. 18/436,343 · Granted Apr 29, 2025

Topical skin compositions for treating rosacea and skin redness

Inventors: Tiffany Carle (Dallas, TX); David Gan (Southlake, TX); Geetha Kalahasti (Plano, TX)
Assignee: MARY KAY INC.
A61K36/889A61K8/922A61K8/9789A61K8/9794A61K8/99A61K9/06A61K9/107A61K35/74A61K36/185A61K36/61A61P17/04A61Q19/007A61Q19/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,285,457
App. No.
18/436,343
Granted
Apr 29, 2025
Kind
B2
Abstract

A method of topically applying to skin a composition comprising a water soluble Phoenix dactylifera seed extract, an essential oil from the leaves of tea tree, an aqueous Myrothamnus flabellifolia leaf and stem extract, and a saccharide isomerate comprising an exopolysaccharide of Vibrio alginolyticus is disclosed.

Claims (32)

1. A method of reducing a dark circle on the skin of a human in need thereof comprising topically applying to the dark circle on the skin of the human in need thereof a cosmetically effective amount of a composition comprising:

Myrothamnus flabellifolia leaf and stem extract;

water;

betaine;

tocopheryl acetate;

disodium EDTA;

PPG-5-ceteth-20;

glycerin;

ammonium acryloyldimethyltaurate/vp copolymer;

cellulose;

titanium dioxide;

butylene glycol;

sodium hydroxide;

citric acid;

oat and/or oat extract;

an algae extract; and

ascorbic acid.

2. The method of claim 1 , wherein the dark circle on the skin of the human includes a fine line or wrinkle.

3. The method of claim 1 , wherein the composition reduces oxidation in the skin.

4. The method of claim 1 , wherein the composition is an emulsion.

5. The method of claim 4 , wherein the emulsion is an oil-in-water emulsion.

6. The method of claim 1 , wherein the composition is a cream or lotion.

7. The method of claim 1 , wherein the composition is a gel.

8. The method of claim 1 , wherein the aqueous Myrothamnus flabellifolia leaf and stem extract reduces tumor necrosis factor alpha (TNF-α) production or inhibits nitric oxide synthase.

9. The method of claim 1 , wherein the composition comprises 0.0001 wt. % to 10 wt. % of the aqueous Myrothamnus flabellifolia leaf and stem extract.

10. The method of claim 1 , wherein the composition comprises at least 50 wt. % water.

11. The method of claim 1 , wherein the composition further comprises a moisturizing agent.

12. The method of claim 1 , wherein the composition further comprises an emulsifier or surfactant.

13. The method of claim 1 , wherein the composition further comprises a ultraviolet light absorption or reflection agent.

14. The method of claim 1 , wherein the composition further comprises a skin lightening agent.

15. The method of claim 1 , wherein the composition lightens skin by reducing vasodilation.

16. The method of claim 1 , wherein the dark circle on the skin of the human in need thereof is a dark area of skin below the eye of the human.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2025
From: MARY KAY INC.
To: ALLUSTRA TECHNOLOGIES LLC
Reel/Frame 071121/0713 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 26, 2024
From: MARY KAY INC.
To: ALLUSTRA TECHNOLOGIES LLC
Reel/Frame 069414/0659 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2024
From: CARLE, TIFFANY; GAN, DAVID; KALAHASTI, GEETHA
To: MARY KAY INC.
Reel/Frame 066416/0545 →
Continuity (5)
Continuation 18100763 · Jan 24, 2023
Continuation 17374549 · Jul 13, 2021
Continuation 16792751 · Feb 17, 2020
Provisional Application 62807141 · Feb 18, 2019
Related Publication 20240342236A1 · Oct 17, 2024
References Cited (38)
US 5972993A · Ptchelintsev · 1999 [cited by applicant]
US 8535738B2 · Collins et al. · 2013 [cited by applicant]
US 9060924B2 · Tawashi et al. · 2015 [cited by applicant]
US 9375462B1 · VanderVeer · 2016 [cited by applicant]
US 9687517B2 · Collins et al. · 2017 [cited by applicant]
US 10543158B2 · Graban et al. · 2020 [cited by applicant]
US 20040081714A1 · Pauly et al. · 2004 [cited by applicant]
US 20050238613A1 · Cals-Grierson et al. · 2005 [cited by applicant]
US 20060198800A1 · Dilallo et al. · 2006 [cited by applicant]
US 20130011349A1 · Tawashi et al. · 2013 [cited by applicant]
US 20150011489A1 · Jacovella · 2015 [cited by applicant]
US 20150104485A1 · Garcia Anton et al. · 2015 [cited by applicant]
US 20170020808A1 · Florence et al. · 2017 [cited by applicant]
US 20170027843A1 · Florence et al. · 2017 [cited by applicant]
US 20180071547A1 · Decaux et al. · 2018 [cited by applicant]
US 20190038689A1 · Kalahasti et al. · 2019 [cited by applicant]
US 20190231677A1 · Norman · 2019 [cited by examiner]
KR 1020160068310 · 2016 [cited by applicant]
WO WO2017180440 · 2017 [cited by applicant]
WO WO2017192110 · 2017 [cited by applicant]
WO WO2017197396 · 2017 [cited by applicant]
WO WO2017204617 · 2017 [cited by applicant]
WO WO2018004490 · 2018 [cited by applicant]
WO WO2018056936 · 2018 [cited by applicant]
“Corneotherapy.” Jan. 24, 2016 and California SCC, Barnet. [cited by applicant]
“Epidermist 4.0: New Skin Builder.” Cosmetics Business, Jul. 22, 2013, https://www.cosmeticsbusiness.com/news/article_page/EPIDERMIST_40_New_Skin_Builder/89190. Accessed Oct. 8, 2021. [cited by applicant]
Ardekani et al., “Comparison of Antioxidant Activity and Total Phenol Contents of some Date Seed Varieties from Iran” [cited by applicant]
Benoiderm Efficacy Report. Technical Dossier 12-073GB Oct. 2012, 46 pages. [cited by applicant]
Cole, Gary W., “Rosacea” [cited by applicant]
Galderma. “About Soolantra Cream” [cited by applicant]
Gollnick et al., “Azelaic acid 15% gel in the treatment of rosacea” [cited by applicant]
International Search Report and Written Opinion issued in corresponding PCT application No. PCT/US2020/018520, dated May 25, 2020. [cited by applicant]
Kwape et al., “Antioxidant and antidiabetic potential of Myrothamnus flabellifolius found in Botswana” [cited by applicant]
Lam et al., “Can the tea tree oil (Australian native plant: [cited by applicant]
Pazyar et al., “A review of applications of tea tree oil in dermatology” [cited by applicant]
Tighe et al., “Terpinen-4-ol is the most active ingredient of tea tree oil to kill Demodex mites” [cited by applicant]
Huang et al., “Research Status of Anti-inflammatory and Anti-bacterial Effect about Tea Tree Oil” [cited by applicant]
Office Action issued in corresponding Chinese Application No. 202080014899.6, dated Jun. 25, 2024 (English Translation provided). [cited by applicant]